{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T01:15:45Z","timestamp":1774574145367,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ongoing Research Funding Program","award":["ORF-2025-339"],"award-info":[{"award-number":["ORF-2025-339"]}]},{"name":"Ongoing Research Funding Program","award":["ORF-2025-339"],"award-info":[{"award-number":["ORF-2025-339"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00619-y","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:04:44Z","timestamp":1750982684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design and evaluation of novel thiazolidinedione-oxadiazole derivatives as potent \u03b1-amylase inhibitors for antidiabetic therapy"],"prefix":"10.1007","volume":"39","author":[{"given":"Pinky","family":"Arora","sequence":"first","affiliation":[]},{"given":"Aditi","family":"Rana","sequence":"additional","affiliation":[]},{"given":"Azmat Ali","family":"Khan","sequence":"additional","affiliation":[]},{"given":"Amer M.","family":"Alanazi","sequence":"additional","affiliation":[]},{"given":"Pankaj","family":"Wadhwa","sequence":"additional","affiliation":[]},{"given":"Sonia","family":"Singla","sequence":"additional","affiliation":[]},{"given":"Shubham","family":"Kumar","sequence":"additional","affiliation":[]},{"given":"Rubal","family":"kalra","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"issue":"1","key":"619_CR1","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/nrdp.2017.23","volume":"3","author":"CR Kahn","year":"2017","unstructured":"Kahn CR, Weir GC (2017) The complex physiology of diabetes mellitus. Nat Reviews Disease Primers 3(1):17023\u201317032","journal-title":"Nat Reviews Disease Primers"},{"key":"619_CR2","doi-asserted-by":"crossref","unstructured":"Harding JL, Weber MB, Shaw JE (2024) The global burden of diabetes. Textbook Diabetes, 28\u201340","DOI":"10.1002\/9781119697473.ch3"},{"key":"619_CR3","first-page":"102993","volume-title":"Phenotypic clusters of type 2 diabetes mellitus among North Indians reveal higher levels of insulin deficiency along with insulin resistance","author":"I Arora","year":"2024","unstructured":"Arora I, Raizada N, Aslam M, Madhu S (2024) Phenotypic clusters of type 2 diabetes mellitus among North Indians reveal higher levels of insulin deficiency along with insulin resistance, vol 18. Clinical Research & Reviews, Diabetes & Metabolic Syndrome, p 102993. 3"},{"key":"619_CR4","doi-asserted-by":"crossref","unstructured":"Berbudi A, Khairani S, Tjahjadi AI (2025) Interplay between insulin resistance and immune dysregulation in type 2 diabetes mellitus: implications for therapeutic interventions. ImmunoTargets Therapy, 359\u2013382","DOI":"10.2147\/ITT.S499605"},{"issue":"3","key":"619_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/kjm2.12800","volume":"40","author":"K Chong","year":"2024","unstructured":"Chong K, Chang JKJ, Chuang LM (2024) Recent advances in the treatment of type 2 diabetes mellitus using new drug therapies. Kaohsiung J Med Sci 40(3):212\u2013220","journal-title":"Kaohsiung J Med Sci"},{"issue":"6","key":"619_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11906-024-01295-3","volume":"26","author":"R Vareldzis","year":"2024","unstructured":"Vareldzis R, Perez A, Reisin E (2024) Hyperuricemia: an intriguing connection to metabolic syndrome, diabetes, kidney disease, and hypertension. Curr Hypertens Rep 26(6):237\u2013245","journal-title":"Curr Hypertens Rep"},{"key":"619_CR7","doi-asserted-by":"publisher","first-page":"155382","DOI":"10.1016\/j.phymed.2024.155382","volume":"126","author":"L Chen","year":"2024","unstructured":"Chen L, Wang J, Ren Y, Ma Y, Liu J, Jiang H, Liu C (2024) Artesunate improves glucose and lipid metabolism in db\/db mice by regulating the metabolic profile and the MAPK\/PI3K\/Akt signalling pathway. Phytomedicine 126:155382","journal-title":"Phytomedicine"},{"issue":"6","key":"619_CR8","doi-asserted-by":"publisher","first-page":"C1752","DOI":"10.1152\/ajpcell.00154.2024","volume":"328","author":"L Wu","year":"2025","unstructured":"Wu L, Coletta DK (2025) Obesity and type 2 diabetes mellitus: insights from skeletal muscle extracellular matrix remodeling. Am J Physiology-Cell Physiol 328(6):C1752\u2013C1763","journal-title":"Am J Physiology-Cell Physiol"},{"key":"619_CR9","doi-asserted-by":"publisher","first-page":"1149239","DOI":"10.3389\/fendo.2023.1149239","volume":"14","author":"X Zhao","year":"2023","unstructured":"Zhao X, An X, Yang C, Sun W, Ji H, Lian F (2023) The crucial role and mechanism of insulin resistance in metabolic disease. Front Endocrinol 14:1149239","journal-title":"Front Endocrinol"},{"key":"619_CR10","doi-asserted-by":"crossref","unstructured":"Papaetis GS, Sacharidou A, Michaelides IC, Mikellidis KC, Karvounaris SA (2025) Insulin resistance, hyperinsulinemia and atherosclerosis: insights into pathophysiological aspects and future therapeutic prospects. Curr Cardiol Rev, 21(1), E1573403X314035.","DOI":"10.2174\/011573403X314035241006185109"},{"key":"619_CR11","first-page":"3666692","volume":"20211","author":"Q Sun","year":"2021","unstructured":"Sun Q, Li X, Chen P, Chen L, Zhao X (2021) The Beta-Cell function and glucose profile of newly diagnosed acromegalic patients with normal glucose tolerance. Int J Endocrinol 20211:3666692","journal-title":"Int J Endocrinol"},{"issue":"1","key":"619_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2021.10138","volume":"22","author":"SS Shetty","year":"2021","unstructured":"Shetty SS, Kumari S (2021) Fatty acids and their role in type\u20132 diabetes. Experimental Therapeutic Med 22(1):1\u20136","journal-title":"Experimental Therapeutic Med"},{"key":"619_CR13","doi-asserted-by":"crossref","unstructured":"Yang B, Li J, Haller MJ, Schatz DA, Rong L (2023) Modeling the progression of type 2 diabetes with underlying obesity. PLoS Comput Biol, 19(2), e1010914","DOI":"10.1371\/journal.pcbi.1010914"},{"key":"619_CR14","doi-asserted-by":"crossref","unstructured":"Sajiir, H., Wong, K. Y., M\u00fcller, A., Keshvari, S., Burr, L., Aiello, E.,\u2026 Hasnain,S. Z. (2024). Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis. Nature Communications,15(1), 4527.","DOI":"10.1038\/s41467-024-48320-2"},{"key":"619_CR15","doi-asserted-by":"crossref","unstructured":"Rangraze IR, El-Tanani M, Rabbani SA, Babiker R, Matalka II, Rizzo M (2025) Diabetes and its silent partner: A critical review of hyperinsulinemia and its complications. Curr Diabetes Rev, 21(9), e15733998311738","DOI":"10.2174\/0115733998311738240813110032"},{"issue":"2","key":"619_CR16","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1039\/D2RA07247E","volume":"13","author":"MG Srinivasa","year":"2023","unstructured":"Srinivasa MG, Paithankar JG, Birangal SRS, Pai A, Pai V, Deshpande SN, Revanasiddappa BC (2023) Novel hybrids of thiazolidinedione-1,3,4-oxadiazole derivatives: synthesis, molecular docking, MD simulations, ADMET study, in vitro, and in vivo anti-diabetic assessment. RSC Adv 13(2):1567\u20131579","journal-title":"RSC Adv"},{"issue":"9","key":"619_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S2213-8587(24)00127-X","volume":"12","author":"M Abdul-Ghani","year":"2024","unstructured":"Abdul-Ghani M, Maffei P, DeFronzo RA (2024) Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes. Lancet Diabetes Endocrinol 12(9):674\u2013680","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"619_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/14756366.2021.2018682","volume":"37","author":"XY Deng","year":"2022","unstructured":"Deng XY, Ke JJ, Zheng YY, Li DL, Zhang K, Zheng X et al (2022) Synthesis and bioactivities evaluation of oleanolic acid oxime ester derivatives as \u03b1-glucosidase and \u03b1-amylase inhibitors. J Enzyme Inhib Med Chem 37(1):451\u2013461","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"15","key":"619_CR19","doi-asserted-by":"publisher","first-page":"8117","DOI":"10.3390\/ijms23158117","volume":"23","author":"O Ebenezer","year":"2022","unstructured":"Ebenezer O, Jordaan MA, Carena G, Bono T, Shapi M, Tuszynski JA (2022) An overview of the biological evaluation of selected nitrogen-containing heterocycle medicinal chemistry compounds. Int J Mol Sci 23(15):8117","journal-title":"Int J Mol Sci"},{"issue":"2","key":"619_CR20","first-page":"1567","volume":"13","author":"MS Gowdru","year":"2023","unstructured":"Gowdru MS et al (2023) Novel hybrids of thiazolidinedione-1,3,4-oxadiazole derivatives: synthesis, molecular docking, MD simulations, ADMET study, in vitro, and in vivo anti-diabetic assessment. RSC Adv 13(2):1567\u20131579","journal-title":"RSC Adv"},{"issue":"1","key":"619_CR21","first-page":"57","volume":"14","author":"OT Babatunde","year":"2025","unstructured":"Babatunde OT, Bewaji CO, Igunnu A (2025) Protein hydrolysates from Cucumeropsis mannii seed inhibit Alpha-amylase In-vitro: potential for managing postprandial hyperglycemia. Biology Med Nat Prod Chem 14(1):57\u201366","journal-title":"Biology Med Nat Prod Chem"},{"key":"619_CR22","doi-asserted-by":"crossref","unstructured":"Gupta S, Jha S, Rani S, Arora P, Kumar S (2024) Medicinal perspective of 2,4-thiazolidinediones derivatives: an insight into recent advancements. ChemistryOpen, 13(5), e202400147","DOI":"10.1002\/open.202400147"},{"issue":"3","key":"619_CR23","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.3390\/ijms24033024","volume":"24","author":"N Sibiya","year":"2023","unstructured":"Sibiya N et al (2023) Discovery of novel thiazolidinedione-derivatives with multi-modal antidiabetic activities in vitro and in Silico. Int J Mol Sci 24(3):3024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"619_CR24","first-page":"1664","volume":"3","author":"M Nidhar","year":"2025","unstructured":"Nidhar M (2025) Recent progress of antidiabetic agents for the treatment of type 2 diabetes: A mini-review. Int J Pharm Sci Drug Res 3(5):1664\u20131670","journal-title":"Int J Pharm Sci Drug Res"},{"key":"619_CR25","doi-asserted-by":"publisher","first-page":"100700","DOI":"10.1016\/j.chphi.2024.100700","volume":"9","author":"N Akter","year":"2024","unstructured":"Akter N, Saha S, Hossain MA, Uddin KM, Bhat AR, Ahmed S, Kawsar SM (2024) Acylated glucopyranosides: FTIR, NMR, FMO, MEP, molecular docking, dynamics simulation, ADMET and antimicrobial activity against bacterial and fungal pathogens. Chem Phys Impact 9:100700","journal-title":"Chem Phys Impact"},{"key":"619_CR26","doi-asserted-by":"crossref","unstructured":"Ahmed, S., Bhat, A. R., Rahiman, A. K., Dongre, R. S., Hasan, A. H., Niranjan, V.,\u2026 Kawsar, S. M. (2024). Green synthesis, antibacterial and antifungal evaluation of new thiazolidine-2, 4-dione derivatives: molecular dynamic simulation, POM study and identification of antitumor pharmacophore sites. Journal of Biomolecular Structure and Dynamics, 42(20), 10635\u201310651.","DOI":"10.1080\/07391102.2023.2258404"},{"key":"619_CR27","doi-asserted-by":"crossref","unstructured":"Arzine, A., Hadni, H., Boujdi, K., Chebbac, K., Barghady, N., Rhazi, Y.,\u2026 El Yazidi,M. (2024). Efficient Synthesis, Structural Characterization, Antibacterial Assessment,ADME-Tox Analysis, Molecular Docking and Molecular Dynamics Simulations of New Functionalized Isoxazoles. Molecules, 29(14), 3366.","DOI":"10.3390\/molecules29143366"},{"issue":"6","key":"619_CR28","doi-asserted-by":"publisher","first-page":"102093","DOI":"10.1016\/j.jsps.2024.102093","volume":"32","author":"MA Hossain","year":"2024","unstructured":"Hossain MA, Sultana S, Alanazi MM, Hadni H, Bhat AR, Hasan I, Kawsar SM (2024) In vitro antimicrobial, anticancer evaluation, and in Silico studies of Mannopyranoside analogs against bacterial and fungal proteins: acylation leads to improved antimicrobial activity. Saudi Pharm J 32(6):102093","journal-title":"Saudi Pharm J"},{"issue":"3","key":"619_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.37358\/RC.21.3.8446","volume":"72","author":"MAK Sarkar","year":"2021","unstructured":"Sarkar MAK, Hosen MA, Chowdhury TS, Rana KM, Fujii Y, Ozeki Y (2021) Thermochemical, PASS, molecular docking, drug-likeness and in Silico ADMET prediction of cytidine derivatives against HIV-1 reverse transcriptase. Revista De Chim (Rev Chim) 72(3):159\u2013178","journal-title":"Revista De Chim (Rev Chim)"},{"key":"619_CR30","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1134\/S107036321702027X","volume":"87","author":"L Kamala","year":"2017","unstructured":"Kamala L, Veena BS, Lakshmi A, Vasantha PV, P., Sujatha E (2017) Synthesis and antimicrobial activity of novel 5-[(1H-indol-3-yl) methylene] thiazolidine-2,4-dione\u2013[1,2,3] Triazole hybrids. Russ J Gen Chem 87:316\u2013321","journal-title":"Russ J Gen Chem"},{"key":"619_CR31","doi-asserted-by":"publisher","first-page":"103271","DOI":"10.1016\/j.bioorg.2019.103271","volume":"92","author":"G Bansal","year":"2019","unstructured":"Bansal G, Singh S, Monga V, Thanikachalam PV, Chawla P (2019) Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents. Bioorg Chem 92:103271","journal-title":"Bioorg Chem"},{"key":"619_CR32","doi-asserted-by":"crossref","unstructured":"Somani RR, Shirodkar PY (2011) Oxadiazole: A biologically important heterocycle. ChemInform, 42(10)","DOI":"10.1002\/chin.201110251"},{"issue":"1","key":"619_CR33","first-page":"205","volume":"30","author":"SM Zachariah","year":"2015","unstructured":"Zachariah SM, Ramkumar MR, George N, Ashif MS (2015) A review on oxadiazole. Int J Pharm Sci Rev Res 30(1):205\u2013219","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"30","key":"619_CR34","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.2174\/0929867329666220929145619","volume":"30","author":"H Mendes Araujo","year":"2023","unstructured":"Mendes Araujo H, de Moura GA, Rocha YM, Rodrigues JPV, Nicolete R (2023) Oxadiazole derivatives as anticancer and Immunomodulatory agents: A systematic review. Curr Med Chem 30(30):3472\u20133485","journal-title":"Curr Med Chem"},{"issue":"6","key":"619_CR35","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.52711\/0974-360X.2023.00455","volume":"16","author":"N Bhat","year":"2023","unstructured":"Bhat N, Kumar A, Kumar P, Pai A (2023) A comprehensive review on the antidiabetic activity of oxadiazole derivatives. Res J Pharm Technol 16(6):2771\u20132775","journal-title":"Res J Pharm Technol"},{"key":"619_CR36","volume-title":"12.0, MM2 interface program. Structures were drawn using chembiodraw ultra 12.0","author":"ChemBio3D Ultra","year":"1985","unstructured":"ChemBio3D Ultra (1985) 12.0, MM2 interface program. Structures were drawn using chembiodraw ultra 12.0. CambridgeSoft, Cambridge"},{"issue":"1","key":"619_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2174\/1573409913666170519112758","volume":"14","author":"EF da Silva-Junior","year":"2018","unstructured":"da Silva-Junior EF, Franca B, Ribeiro PH, Mendonca-Junior FFB, Scotti FJ, L., Scotti MT (2018) Molecular Docking studies applied to a dataset of Cruzain inhibitors. Curr Comput-Aided Drug Design 14(1):68\u201378","journal-title":"Curr Comput-Aided Drug Design"},{"issue":"2","key":"619_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2174\/1573409914666181019165821","volume":"16","author":"S Kumar","year":"2020","unstructured":"Kumar S, Khatik GL, Mittal A (2020) In Silico molecular Docking study to search new SGLT2 inhibitor based on dioxabicyclo[3.2.1]octane scaffold. Curr Comput-Aided Drug Design 16(2):145\u2013154","journal-title":"Curr Comput-Aided Drug Design"},{"issue":"5","key":"619_CR39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2174\/1573409919666230626113346","volume":"20","author":"S Kumar","year":"2024","unstructured":"Kumar S, Arora P, Wadhwa P, Kaur P (2024) A rationalized approach to design and discover novel non-steroidal derivatives through computational aid for the treatment of prostate cancer. Curr Comput-Aided Drug Design 20(5):575\u2013589. https:\/\/doi.org\/10.2174\/1573409919666230626113346","journal-title":"Curr Comput-Aided Drug Design"},{"key":"619_CR40","doi-asserted-by":"crossref","unstructured":"Mwamafupa A, Arora P, Singh J, Seksaria K, Kumar S (2024) Discovery of \u03b2-carboline based derivatives through computational aid for the treatment of leishmania. Curr Signal Transduct Ther, 19(1), e190124225823","DOI":"10.2174\/0115743624270694231213095103"},{"issue":"4","key":"619_CR41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technol 1(4):337\u2013341","journal-title":"Drug Discovery Today: Technol"},{"issue":"W1","key":"619_CR42","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee P, Eckert AO, Schrey AK, Preissner R (2018) ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 46(W1):W257\u2013W263","journal-title":"Nucleic Acids Res"},{"key":"619_CR43","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.ejmech.2016.08.029","volume":"124","author":"P Sharma","year":"2016","unstructured":"Sharma P, Reddy TS, Thummuri D, Senwar KR, Kumar NP, Naidu VGM, Bhargava SK, Shankaraiah N (2016) Synthesis and biological evaluation of new benzimidazole-thiazolidinedione hybrids as potential cytotoxic and apoptosis inducing agents. Eur J Med Chem 124:608\u2013621","journal-title":"Eur J Med Chem"},{"key":"619_CR44","doi-asserted-by":"publisher","first-page":"107029","DOI":"10.1016\/j.bioorg.2023.107029","volume":"143","author":"S Kumar","year":"2024","unstructured":"Kumar S, Wadhwa P (2024) Synthesis, molecular Docking and biological evaluation of 1,2,4-oxadiazole based novel non-steroidal derivatives against prostate cancer. Bioorg Chem 143:107029. https:\/\/doi.org\/10.1016\/j.bioorg.2023.107029","journal-title":"Bioorg Chem"},{"issue":"16","key":"619_CR45","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1016\/j.bmcl.2017.06.069","volume":"27","author":"SNC Sridhar","year":"2017","unstructured":"Sridhar SNC, Bhurta D, Kantiwal D, George G, Monga V, Paul AT (2017) Design, synthesis, biological evaluation and molecular modelling studies of novel diaryl substituted Pyrazolyl Thiazolidinediones as potent pancreatic lipase inhibitors. Bioorg Med Chem Lett 27(16):3749\u20133754","journal-title":"Bioorg Med Chem Lett"},{"key":"619_CR46","doi-asserted-by":"crossref","unstructured":"Tripathi, A. C., Gupta, S. J., Fatima, G. N., Sonar, P. K., Verma, A., & Saraf, S.K. (2014). 4-Thiazolidinones: The advances continue\u2026 European Journal of Medicinal Chemistry, 72, 52\u201377.","DOI":"10.1016\/j.ejmech.2013.11.017"},{"issue":"7","key":"619_CR47","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1021\/jm1011534","volume":"54","author":"G Marc","year":"2011","unstructured":"Marc G, Xie C, Zheng H, Chen Z, Xu Q, Chen T, Chen J (2011) Synthesis and biological evaluation of novel 5-benzylidenethiazolidine-2,4-dione derivatives for the treatment of microbial diseases. J Med Chem 54(7):2060\u20132068","journal-title":"J Med Chem"},{"key":"619_CR48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ejmech.2015.12.049","volume":"109","author":"KM Darwish","year":"2016","unstructured":"Darwish KM, Salama I, Mostafa S, Gomaa MS, Helal MA (2016) Design, synthesis, and biological evaluation of novel Thiazolidinediones as PPAR\u03b3\/FFAR1 dual agonists. Eur J Med Chem 109:157\u2013172","journal-title":"Eur J Med Chem"},{"key":"619_CR49","doi-asserted-by":"publisher","first-page":"135596","DOI":"10.1016\/j.molstruc.2023.135596","volume":"1287","author":"S Gupta","year":"2023","unstructured":"Gupta S, Baweja GS, Gupta GD, Asati V (2023) Identification of potential N-substituted 5-benzylidenethiazolidine-2,4-dione derivatives as \u03b1-amylase inhibitors: computational cum synthetic studies. J Mol Struct 1287:135596","journal-title":"J Mol Struct"},{"key":"619_CR50","doi-asserted-by":"crossref","unstructured":"Garg P, Rawat RS, Bhatt H, Kumar S, Reddy SR (2022) Recent developments in the synthesis of N-heterocyclic compounds as \u03b1\u2010amylase inhibitors via in\u2010vitro and in\u2010silico analysis: future drugs for treating diabetes. ChemistrySelect, 7(28)","DOI":"10.1002\/slct.202201706"},{"key":"619_CR51","doi-asserted-by":"crossref","unstructured":"Babagond, V., Katagi, K., Akki, M., Kamat, V., Barretto, D. A., Jaggal, A.,\u2026 Shirahatti,A. (2025). A Click Chemistry Approach for the Synthesis of Triazole Linked Vanillin Scaffolds as Potent Pharmacophores: Anti-Diabetic, Anti-Inflammatory, Antioxidant,Molecular Docking and ADMET Investigations. Polycyclic Aromatic Compounds, 1\u201324.","DOI":"10.1080\/10406638.2025.2507335"},{"key":"619_CR52","doi-asserted-by":"crossref","unstructured":"Kaya, B., Acar \u00c7evik, U., \u00c7ift\u00e7i, B., Duran, H. E., T\u00fcrke\u015f, C., I\u015f\u0131k, M.,\u2026 Beydemir,S. (2024). Synthesis, \u03b1-Glucosidase, \u03b1-Amylase, and Aldol Reductase Inhibitory Activity with Molecular Docking Study of Novel Imidazo [1, 2-a] pyridine Derivatives. ACS omega, 9(42), 42905\u201342914.","DOI":"10.1021\/acsomega.4c05619"},{"issue":"1","key":"619_CR53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40203-024-00205-4","volume":"12","author":"KS Aminu","year":"2024","unstructured":"Aminu KS, Uzairu A, Chandra A, Singh N, Abechi SE, Shallangwa GA, Umar AB (2024) Exploring the potential of 2-arylbenzimidazole scaffolds as novel \u03b1-amylase inhibitors: QSAR, molecular docking, simulation and Pharmacokinetic studies. Silico Pharmacol 12(1):29","journal-title":"Silico Pharmacol"},{"key":"619_CR54","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2174\/1874842201805010134","volume":"5","author":"F Naeem","year":"2018","unstructured":"Naeem F, Nadeem H, Muhammad A, Zahid AM, Saeed A (2018) Synthesis, \u03b1\u2013amylase inhibitory activity and molecular Docking studies of 2,4\u2013thiazolidinedione derivatives. Open Chem J 5:134\u2013144","journal-title":"Open Chem J"},{"key":"619_CR55","doi-asserted-by":"crossref","unstructured":"Singh, R., Sindhu, J., Devi, M., Kumar, P., Lal, S., Kumar, A.,\u2026 Kumar, H. (2024).Synthesis of thiazolidine-2, 4-dione tethered 1, 2, 3-triazoles as \u03b1-amylase inhibitors: in vitro approach coupled with QSAR, molecular docking, molecular dynamics and ADMET studies. European Journal of Medicinal Chemistry, 275, 116623.","DOI":"10.1016\/j.ejmech.2024.116623"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00619-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00619-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00619-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:55:51Z","timestamp":1762451751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00619-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00619-y","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}